83 Results

People

  1. Scher
    Scher
  2. Gonen
    Gonen
  3. Aghajanian
    Aghajanian
  4. Heller
    Heller
  5. Iasonos
    Iasonos
  6. Morris
    Morris
  7. Patil
    Patil
  8. Seshan
    Seshan
  9. Hensley
    Hensley
  10. Sabbatini
    Sabbatini

Groups

  1. Department of Medicine (83)
  2. Epidemiology and Biostatistics (83)
  3. Biostatistics Service (73)
  4. Solid Tumor Oncology Division (73)
  5. Genitourinary Oncology Service (30)
  6. Surgery (30)
  7. Center for Pancreatic Cancer Research (29)
  8. GSK Faculty (24)
  9. Radiology, Department of (24)
  10. Survivorship Research (21)
  1. "cancer growth"
  2. "Epidemiology and Biostatistics"
  3. "Department of Medicine"
Formats
  1. Journal Article (81)
  2. Correspondence (1)
  3. Research Letter (1)
Groups
  1. Department of Medicine (83)
  2. Epidemiology and Biostatistics (83)
  3. Biostatistics Service (73)
  4. Solid Tumor Oncology Division (73)
  5. Genitourinary Oncology Service (30)
  6. Surgery (30)

More Groups

People
  1. Howard Scher (14)
  2. Mithat Gonen (12)
  3. Carol Aghajanian (11)
  4. Glenn Heller (11)
  5. Alexia Iasonos (9)
  6. Michael Morris (8)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (2)
  4. 2020 (7)
  5. 2019 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Clinical Cancer Research (12)
  3. Gynecologic Oncology (9)
  4. Cancer (5)
  5. Annals of Oncology (3)
  6. Urology (3)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. Elsevier Inc. (14)
  3. American Society of Clinical Oncology (13)
  4. Elsevier Science, Inc. (9)
  5. Wiley Blackwell (6)
  6. Nature Publishing Group (5)

More Publishers

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: The BOND-2 study
    Journal Article

    Saltz, L. B.; Lenz, H. J.; Kindler, H. L.; Hochster, H. S.; Wadler, S.; Hoff, P. M.; Kemeny, N. E.; Hollywood, E. M.; Gonen, M.; Quinones, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer
    Journal Article

    Sabbatini, P. J.; Ragupathi, G.; Hood, C.; Aghajanian, C. A.; Juretzka, M.; Iasonos, A.; Hensley, M. L.; Spassova, M. K.; Ouerfelli, O.; Spriggs, D. R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma
    Journal Article

    Krug, L. M.; Heelan, R. T.; Kris, M. G.; Venkatraman, E.; Sirotnak, F. M.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials
    Journal Article

    Harrison, M. L.; Gore, M. E.; Spriggs, D.; Kaye, S.; Iasonos, A.; Hensley, M.; Aghajanian, C.; Venkatraman, E.; Sabbatini, P.
    Gynecologic Oncology (2007)

    Fulltext@MSK | Save
  • Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis
    Journal Article

    Gallagher, D. J.; Capanu, M.; Raggio, G.; Kemeny, N.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression
    Journal Article

    Cotignola, J.; Roy, P.; Patel, A.; Ishill, N.; Shah, S.; Houghton, A.; Coit, D.; Halpern, A.; Busam, K.; Berwick, M.; more...
    Journal of Negative Results in BioMedicine (2007)

    Fulltext@MSK | Save
  • Unconventional anticancer agents: A systematic review of clinical trials
    Journal Article

    Vickers, A. J.; Kuo, J.; Cassileth, B. R.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning
    Journal Article

    Hensley, M. L.; Correa, D. D.; Thaler, H.; Wilton, A.; Venkatraman, E.; Sabbatini, P.; Chi, D. S.; Dupont, J.; Spriggs, D.; Aghajanian, C.
    Gynecologic Oncology (2006)

    Fulltext@MSK | Save
  • Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy
    Journal Article

    Morris, M. J.; Akhurst, T.; Larson, S. M.; Ditullio, M.; Chu, E.; Siedlecki, K.; Verbel, D.; Heller, G.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save